Table 4 Impact of renal protection fluid therapy on outcome

β (95 % CI)

P value

β (95 % CI)

P value

β (95 % CI)

P value

Extubation time (h)

−0.28 (−0.37, −0.18)

<0.001

−0.28 (−0.37, −0.19)

<0.001

−0.33 (−0.42, −0.23)

<0.001

Intensive care unit stay (h)

0.02 (−0.06, 0.09)

0.682

0.03 (−0.04, 0.10)

0.400

−0.06 (−0.13, 0.02)

0.159

Hospital stay (d)

−0.11 (−0.17, −0.04)

0.001

−0.11 (−0.17, −0.05)

<0.001

−0.18 (−0.24, −0.11)

<0.001

OR (95 % CI)

P value

OR (95 % CI)

P value

OR (95 % CI)

P value

Acute kidney injury by KDIGO

0.28 (0.18–0.41)

<0.001

0.31 (0.19–0.50)

<0.001

0.23 (0.15–0.35)

<0.001

KDIGO stage ≥2

0.28 (0.13–0.60)

0.001

0.30 (0.12–0.75)

0.009

0.12 (0.04–0.36)

<0.001

Renal replacement therapy

0.40 (0.09–1.79)

0.230

–

–

–

–

Persistent acute kidney injury

0.16 (0.06–0.45)

<0.001

0.20 (0.06–0.67)

0.008

0.20 (0.08–0.52)

0.001

In-hospital death

0.34 (0.04–2.80)

0.318

–

–

–

–